Dysregulation of potentially pathogenic self reactivity is crucial for the manifestation of clinical autoimmunity

Journal of Neuroscience Research

Volumn 45, Issue 4, 1996, Pages 334-339

  Kumar, Vipin ^a   Sercarz, E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

autoimmune disease; peripheral tolerance; T cell receptor peptide specific regulatory T cells; Th1 Th2 balance

Indexed keywords

MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL SPECIFICITY; EFFECTOR CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; SELF TOLERANCE;

EID: 0029759169     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960815)45:4<334::AID-JNR2>3.0.CO;2-A     Document Type: Article

References (27)

1. Bell RB, Lindsey JW, Sobel RA, Hodkinson S, Steinman L (1992): Diverse T cell receptor V beta gene usage in the central nervous system in experimental allergic encephalomyelitis. J Immunol 150:4085-4092.
2. Cserr HF, Knopf PM (1992): Cervical lymphatics, the blood brain barrier and the immunoreactivity of the brain: a new view. Immunol Today 13:507-512.
3. + cells in T cell receptor peptide-induced clonal unresponsiveness. Science 259:91-94.
4. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM (1993): Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551-560.
5. Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW (1989): Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246:668-670.
6. + T cells in experimental allergic encephalomyelitis. Science 256:1213-1215.
7. -/- mice. Science 256:1210-1213.
8. Kumar V, Sercarz E (1992): T cell regulatory circuitry: Antigen-specific and TCR-idiopeptide-specific T cell interactions in EAE. Int Rev Immunol 9:269-279.
9. + T cells in recovery from antigen-induced autoimmune disease. J Exp Med 178:909-916.
10. Kumar V, Kono D, Urban J, Hood L (1988): T cell receptor repertoire and autoimmune diseases. Ann Rev Immunol 7:657-682.
11. Kumar V, Tabibiazar R, Geysen HM, Sercarz E (1995a): The dominant self-TCR peptide from the framework III region of the β-chain controls murine EAE. J Immunol 154:1941-1950.
12. Kumar V, Bhardwaj V, Soares L, Alexander J, Sette A, Sercarz E (1995b): MHC-ligand affinity of an antigenic determinant is crucial for differential secretion of IFN-γ or IL-4 by T cells. Proc Natl Acad Sci USA 92:9510-9514.
13. Kumar V, Stellrecht K, Sercarz L (1996): Inactivation of TCR peptide-specific CD4 regulatory T cells induces chronic EAE. Submitted.
14. Kumar V, Coulsell E, Ober B, Hubbard G, Sercarz E, Sallward E (1996): Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis. Submitted.
15. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S (1994): High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient antimyelin basic protein T cell receptor transgenic mice. Cell 78:399-408.
16. Lehmann PV, Sercarz EE, Forethuber T, Dayan CM, Gammon G (1993): Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 14:203-208.
17. Liu GY, Fairchild PJ, Smith RM, Prowle JR, Kioussis D, Wraith DC (1995): Low avidity recognition of self antigen by T cells permits escape from central tolerance. Immunity 3:407-415.
18. Mason D, Fowell D (1992): T-cell subsets in autoimmunity. Curr Opin Immunol 4:728-732.
19. Mathisen PM, Pease S, Garvey J, Hood L, Readhead C (1993): Identification of an embryonic isoform of myelin basic protein that is expressed widely in the mouse embryo. Proc Natl Acad Sci USA 90:100125-10129.
20. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD (1995): Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 182:75-85.
21. O'Garra A, Murphy K (1993): T-cell subsets in autoimmunity. Curr Opin Immunol 5:880-886.
22. Paterson PY (1981): Multiple sclerosis: an immunological reassessment. J Chronic Dis 26:119-125.
23. Perry LL, Barzaga ME (1987): Kinetics and specificity of T and B cell responses in relapsing experimental allergic encephalomyelitis. J Immunol 147:1434-1441.
24. Pribyl TM, Campagnoni CW, Kampf K, Kashima T, Handley VW, McMahon J, Campagnoni AT (1993): The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems. Proc Natl Acad Sci USA 90:10695-10699.
25. Urban JL, Kumar V, Kono DH, Gomez C, Horvath SJ, Clayton J, Ando DG, Sercarz EE, Hood L (1988): Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577-592.
26. Vainiene M, Celnik B, Vandenbark AA, Hashim GA, Offner H (1996): Natural immunodominant and experimental autoimmune encephalomyelitis-protective determinants within the Lewis rat VB8.2 sequence include CDR2 and framework 3 idiotopes. J Immunol 43:137-145.
27. Vandenbark AA, Hashim G, Offner H (1989): Immunization with a synthetic T cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541-544.